Descrição:

NSABP PROTOCOL B-38Treatment Form for Group 2 - Doxorubicin, Cyclophosphamide Followed by Paclitaxel (DD AC - P) - Form T2 NCT00093795 Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD882133-10FD-25D3-E034-0003BA12F5E7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD882133-10FD-25D3-E034-0003BA12F5E7
Palavras-chave:
  1. 18/12/2014 18/12/2014 - Martin Dugas
  2. 09/01/2015 09/01/2015 - Martin Dugas
  3. 16/06/2015 16/06/2015 -
Transferido a:

16 de junho de 2015

DOI:
Para um pedido faça login.
Licença :
Creative Commons BY-NC 3.0 Legacy
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

NSABP PROTOCOL B-38Treatment Form for Group 2 - Doxorubicin, Cyclophosphamide Followed by Paclitaxel (DD AC - P) - Form T2 NCT00093795

No Instruction available.

  1. StudyEvent: NSABP PROTOCOL B-38Treatment Form for Group 2 - Doxorubicin, Cyclophosphamide Followed by Paclitaxel (DD AC - P) - Form T2
    1. No Instruction available.
Assessment of Chemotherapy
Are data amended? (check box if yes, and circle amended items)
Agent Name (Agent Total Dose* mg/m^2)
Was this cycle delayed due to adverse event(s)? (Circle Y or N for Yes, No)
Reason Treatment Ended (or Never Started Select only one)

Similar models

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial